SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-003191
Filing Date
2019-02-19
Accepted
2019-02-19 07:33:12
Documents
77
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sage-10k_20181231.htm 10-K 3433851
2 EX-21.1 sage-ex211_9.htm EX-21.1 8250
3 EX-23.1 sage-ex231_10.htm EX-23.1 2229
4 EX-31.1 sage-ex311_8.htm EX-31.1 9317
5 EX-31.2 sage-ex312_7.htm EX-31.2 9253
6 EX-32.1 sage-ex321_6.htm EX-32.1 7636
7 GRAPHIC g1oxikyb1crb000002.jpg GRAPHIC 22445
8 GRAPHIC g1oxikyb1crb000003.jpg GRAPHIC 35704
9 GRAPHIC g1oxikyb1crb000001.jpg GRAPHIC 35647
  Complete submission text file 0001564590-19-003191.txt   10393217

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT sage-20181231.xml EX-101.INS 2227847
11 XBRL TAXONOMY EXTENSION SCHEMA sage-20181231.xsd EX-101.SCH 60570
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20181231_cal.xml EX-101.CAL 50281
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20181231_def.xml EX-101.DEF 209419
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20181231_lab.xml EX-101.LAB 455899
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20181231_pre.xml EX-101.PRE 375484
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36544 | Film No.: 19613409
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences